Krystian Kidrycki

ROS 1 and EGFR next-generation tyrosine kinase inhibitors in advanced non-small-cell lung cancer

M. Krzakowski, P. Rutkowski, P. Golusiński, 2019 .

The usefulness of an 18 F-FDG-PET / MR examination in a patient with rectal and breast cancer

M. Wojtukiewicz, E. Sierko, D. Hempel, 2019 .

Screening for colorectal cancer

K. Kurek, J. Wasielica-Berger, Krystian Kidrycki, 2018 .